本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

70.82
-3.5800-4.81%
盘后:70.820.00000.00%17:56 EDT
成交量:163.28万
成交额:1.17亿
市值:31.08亿
市盈率:-65.43
高:75.02
开:74.50
低:70.32
收:74.40
52周最高:91.53
52周最低:53.89
股本:4,388.30万
流通股本:3,563.83万
量比:2.29
换手率:4.58%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
净资产收益率:-13.68%
总资产收益率:-5.48%
市净率:8.96
市盈率(LYR):-44.54

数据加载中...

2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/11

重要事件披露

Form 8-K - Current report
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/18

SEC问询函

Form CORRESP - Correspondence
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]